Table 1.
Patient Characteristics in 4 Glioma Subtypes
| Subtype | No. of Patients | F/M | Mean age ± SD (min–max) (years) |
|---|---|---|---|
| Mut | 22 | 14/8 | 37.7 ± 9.9 (21–55) |
| DA IDH-mut | 8 | 8/0 | 37.6 ± 9.5 (27–50) |
| AA IDH-mut | 14 | 6/8 | 37.7 ± 10.5 (21–55) |
| Codel | 14 | 9/5 | 48.3 ± 15.0 (28–71) |
| OD | 6 | 5/1 | 42.2 ± 10.1 (31–60) |
| AO | 8 | 4/4 | 52.9 ± 17.0 (28–71) |
| Wt | 14 | 6/8 | 63.1 ± 13.3 (35–79) |
| DA IDH-wt | 5 | 1/4 | 58.6 ± 13.6 (35–69) |
| AA IDH-wt | 9 | 5/4 | 65.7 ± 13.3 (35–79) |
| GBM | 63 | 31/32 | 63.7 ± 14.8 (26–86) |
| GBM IDH-mut | 5 | 2/3 | 37.4 ± 6.7 (27–45) |
| GBM IDH-wt | 58 | 29/29 | 66.0 ± 13.0 (26–86) |
Following 4 glioma subtypes; Mut, Codel, Wt, and GBM.
Mut; DA IDH-mut and AA IDH-mut, Codel; OD and AO, Wt; DA IDH-wt and AA IDH-wt, GBM; GBM IDH-mut and GBM IDH-wt.
AA, anaplastic astrocytoma; AO, anaplastic oligodendroglioma; DA, diffuse astrocytoma; GBM, glioblastoma multiforme; IDH, isocitrate dehydrogenase; mut, mutation; OD, oligodendroglioma; PET, positron emission tomography; wt, wild type.